|
DE2847693A1
(de)
*
|
1978-11-03 |
1980-05-22 |
Hoechst Ag |
Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
|
|
US4814335A
(en)
*
|
1982-12-30 |
1989-03-21 |
Biomeasure, Incorporated |
Antiviral compounds
|
|
US4625026A
(en)
*
|
1982-12-30 |
1986-11-25 |
Biomeasure, Inc. |
2-amino-4-oxo-tricyclicpyrimidines having antiviral activities against herpes simplex virus type II infections
|
|
JPS6442472A
(en)
*
|
1987-08-10 |
1989-02-14 |
Kanebo Ltd |
Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
|
|
US4877790A
(en)
*
|
1987-12-15 |
1989-10-31 |
Kanebo Limited |
Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
|
|
TW334434B
(en)
*
|
1995-05-16 |
1998-06-21 |
Kanebo Ltd |
Novel quinazoline compound and anti-tumor agent
|
|
WO1997042192A1
(de)
*
|
1996-05-07 |
1997-11-13 |
Basf Aktiengesellschaft |
Imidazo-chinazoline, sie enthaltende mittel und deren verwendung zur bekämpfung von schadpilzen und tierischen schädlingen
|
|
DE60110844T2
(de)
*
|
2001-01-02 |
2006-01-12 |
F. Hoffmann-La Roche Ag |
Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
|
|
US6900220B2
(en)
|
2001-01-02 |
2005-05-31 |
Syntex (U.S.A.) Llc |
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
|
|
EP1389224B1
(en)
*
|
2001-05-14 |
2010-01-13 |
Omnova Soltions Inc |
Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups
|
|
EP1398032A1
(en)
*
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
EP1407774A1
(en)
*
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
DK1557414T3
(da)
|
2002-10-01 |
2012-05-29 |
Mitsubishi Tanabe Pharma Corp |
IsoquinoIin-forbindelser og medicinsk anvendelse deraf
|
|
ATE540928T1
(de)
|
2002-11-22 |
2012-01-15 |
Mitsubishi Tanabe Pharma Corp |
Isochinolinverbindungen und ihre medizinische verwendung
|
|
US7928104B2
(en)
|
2003-11-20 |
2011-04-19 |
Dominique Jean-Pierre Mabire |
7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
|
|
AU2004295058B9
(en)
|
2003-11-20 |
2011-06-30 |
Janssen Pharmaceutica N.V. |
6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
|
|
NZ551801A
(en)
|
2004-06-30 |
2009-11-27 |
Janssen Pharmaceutica Nv |
Quinazolinedione derivatives as PARP inhibitors
|
|
NZ551799A
(en)
|
2004-06-30 |
2009-11-27 |
Janssen Pharmaceutica Nv |
Phthalazine derivatives as PARP inhibitors
|
|
ATE498613T1
(de)
|
2004-06-30 |
2011-03-15 |
Janssen Pharmaceutica Nv |
Chinazolinonderivate als parp-hemmer
|
|
CN102372704B
(zh)
*
|
2005-02-18 |
2014-10-08 |
田边三菱制药株式会社 |
脯氨酸衍生物的盐，其溶剂合物，及其生产方法
|
|
PL2007752T3
(pl)
|
2006-03-31 |
2011-02-28 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-ilopirymidyny i pirazyny jako modulatory receptora histaminowego H4
|
|
JP5545955B2
(ja)
|
2007-03-08 |
2014-07-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｐａｒｐおよびｔａｎｋ阻害剤としてのキノリノン誘導体
|
|
EP2215075B1
(en)
|
2007-10-26 |
2013-12-11 |
Janssen Pharmaceutica, N.V. |
Quinolinone derivatives as parp inhibitors
|
|
RU2490260C2
(ru)
|
2008-03-27 |
2013-08-20 |
Янссен Фармацевтика Нв |
Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибиторов parp и ингибиторов полимеризации тубулина
|
|
WO2009118384A1
(en)
|
2008-03-27 |
2009-10-01 |
Janssen Pharmaceutica Nv |
Quinazolinone derivatives as tubulin polymerization inhibitors
|
|
US9371311B2
(en)
|
2008-06-30 |
2016-06-21 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyrimidine derivatives
|
|
EA020090B1
(ru)
*
|
2008-06-30 |
2014-08-29 |
Янссен Фармацевтика Нв |
Способ получения и рекристаллизации кристаллического гемитартрата бензоимидазол-2-илпиримидинового производного
|
|
US9040508B2
(en)
|
2008-12-08 |
2015-05-26 |
Vm Pharma Llc |
Compositions of protein receptor tyrosine kinase inhibitors
|
|
US8987444B2
(en)
*
|
2010-01-18 |
2015-03-24 |
Msn Laboratories Private Limited |
Process for the preparation of amide intermediates and their use thereof
|
|
WO2012131706A1
(en)
*
|
2011-03-20 |
2012-10-04 |
Cadila Healthcare Limited |
Amorphous form of vilazodone hydrochloride and process for its preparation
|
|
DE102011113749A1
(de)
*
|
2011-09-14 |
2013-03-14 |
Aicuris Gmbh & Co. Kg |
Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
|
|
JP2014528427A
(ja)
*
|
2011-09-30 |
2014-10-27 |
ヤンセン ファーマシューティカ エヌ．ベー． |
（１−（４−フルオロフェニル）−１ｈ−インドール−５−イル）−（３−（４−（チアゾール−２−カルボニル）ピペラジン−１−イル）アゼチジン−１−イル）メタノンの結晶性塩酸塩、並びに疼痛及び代謝障害の処置におけるその使用
|
|
ES2698298T3
(es)
|
2012-03-15 |
2019-02-04 |
Celgene Car Llc |
Sales de un inhibidor de quinasa receptor de factor de crecimiento epidérmico
|
|
JP6317319B2
(ja)
*
|
2012-03-15 |
2018-04-25 |
セルジーン シーエーアール エルエルシー |
上皮成長因子受容体キナーゼ阻害剤の固体形態
|
|
US20130261134A1
(en)
*
|
2012-03-30 |
2013-10-03 |
Boehringer Ingelheim International Gmbh |
Mesylate salt forms of a potent hcv inhibitor
|
|
PE20151274A1
(es)
|
2013-02-08 |
2015-09-12 |
Celgene Avilomics Res Inc |
Inhibidores de erk y sus usos
|
|
UY35370A
(es)
|
2013-03-06 |
2014-09-30 |
Janssen Pharmaceutica Nv |
Moduladores benzoimidazol-2-il pirimidina del receptor de histamina h4
|
|
US8999992B2
(en)
|
2013-03-15 |
2015-04-07 |
Vm Pharma Llc |
Crystalline forms of tryosine kinase inhibitors and their salts
|
|
SG11201604517WA
(en)
*
|
2013-12-03 |
2016-07-28 |
Amgen Inc |
Crystalline forms of n-(4-((3-(2-amino-4-pyrimidinyl) - 2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1 -phthalazinamine pharmaceutically acceptable salts and uses thereof
|
|
DK3179858T3
(da)
|
2014-08-13 |
2019-07-22 |
Celgene Car Llc |
Forme og sammensætninger af en ERK-inhibitor
|
|
JP2017529356A
(ja)
|
2014-09-17 |
2017-10-05 |
ムンディファーマ インターナショナル コーポレイション リミテッド |
チロシンキナーゼ阻害剤及びその塩の結晶形態
|
|
CN112645933B
(zh)
*
|
2016-03-22 |
2022-02-11 |
江苏豪森药业集团有限公司 |
Egfr抑制剂游离碱或其酸式盐的多晶型、其制备方法和应用
|